A detailed history of Verus Financial Partners, Inc. transactions in Elevance Health, Inc. stock. As of the latest transaction made, Verus Financial Partners, Inc. holds 1,714 shares of ELV stock, worth $627,255. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,714
Previous 1,713 0.06%
Holding current value
$627,255
Previous $928,000 3.99%
% of portfolio
0.1%
Previous 0.11%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$500.12 - $562.29 $500 - $562
1 Added 0.06%
1,714 $891,000
Q2 2024

Aug 05, 2024

SELL
$497.49 - $547.8 $47,261 - $52,040
-95 Reduced 5.25%
1,713 $928,000
Q1 2024

May 07, 2024

BUY
$464.61 - $519.96 $464 - $519
1 Added 0.06%
1,808 $937,000
Q4 2023

Feb 06, 2024

SELL
$433.51 - $488.06 $20,808 - $23,426
-48 Reduced 2.59%
1,807 $852,000
Q3 2023

Oct 23, 2023

BUY
$414.13 - $475.93 $414 - $475
1 Added 0.05%
1,855 $807,000
Q1 2023

May 05, 2023

SELL
$446.3 - $502.2 $88,813 - $99,937
-199 Reduced 9.69%
1,854 $852,000
Q4 2022

Feb 01, 2023

SELL
$465.23 - $546.77 $51,175 - $60,144
-110 Reduced 5.09%
2,053 $1.05 Million
Q3 2022

Oct 31, 2022

BUY
$445.98 - $507.0 $445 - $507
1 Added 0.05%
2,163 $1.03 Million
Q2 2022

Aug 03, 2022

SELL
$444.32 - $529.84 $20,438 - $24,372
-46 Reduced 2.08%
2,162 $999,000
Q1 2022

Apr 15, 2022

BUY
$428.44 - $502.48 $428 - $502
1 Added 0.05%
2,208 $1.13 Million
Q3 2021

Oct 29, 2021

SELL
$357.51 - $398.13 $6,792 - $7,564
-19 Reduced 0.85%
2,207 $857,000
Q2 2021

Jul 23, 2021

SELL
$352.19 - $401.9 $50,715 - $57,873
-144 Reduced 6.08%
2,226 $868,000
Q1 2021

Apr 27, 2021

BUY
$287.7 - $371.31 $14,960 - $19,308
52 Added 2.24%
2,370 $835,000
Q4 2020

Feb 10, 2021

BUY
$270.17 - $333.15 $626,254 - $772,241
2,318 New
2,318 $744,000
Q3 2020

Nov 03, 2020

SELL
$245.73 - $284.63 $648,727 - $751,423
-2,640 Closed
0 $0
Q2 2020

Jul 31, 2020

SELL
$203.3 - $300.59 $30,088 - $44,487
-148 Reduced 5.31%
2,640 $694,000
Q1 2020

Apr 09, 2020

BUY
$174.68 - $307.74 $2,270 - $4,000
13 Added 0.47%
2,788 $633,000
Q4 2019

Jan 21, 2020

SELL
$234.82 - $306.42 $18,081 - $23,594
-77 Reduced 2.7%
2,775 $838,000
Q3 2019

Oct 15, 2019

SELL
$237.69 - $310.48 $18,302 - $23,906
-77 Reduced 2.63%
2,852 $685,000
Q2 2019

Aug 05, 2019

SELL
$236.25 - $293.76 $25,987 - $32,313
-110 Reduced 3.62%
2,929 $827,000
Q1 2019

Apr 19, 2019

BUY
$248.42 - $317.42 $514,229 - $657,059
2,070 Added 213.62%
3,039 $872,000
Q3 2018

Nov 09, 2018

BUY
$238.27 - $274.12 $11,436 - $13,157
48 Added 5.21%
969 $265,000
Q2 2018

Jul 16, 2018

SELL
$220.13 - $245.16 $14,528 - $16,180
-66 Reduced 6.69%
921 $219,000
Q1 2018

Apr 23, 2018

BUY
$215.63 - $258.19 $14,662 - $17,556
68 Added 7.4%
987 $217,000
Q4 2017

Jan 29, 2018

BUY
$183.76 - $234.96 $168,875 - $215,928
919
919 $207,000

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $87.8B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track Verus Financial Partners, Inc. Portfolio

Follow Verus Financial Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verus Financial Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Verus Financial Partners, Inc. with notifications on news.